Novavax (NVAX) Raises $200M from Private Placement with RA Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Novavax (NVAX) Announces David Mott to Board
June 16, 2020 8:09 AM EDTANovavax, Inc. (NASDAQ: NVAX) today announced that it has appointed David Mott as an independent director to its Board of Directors. Mr. Mott brings more than three decades of global management, board and investment experience across numerous private and public biopharmaceutical companies. Prior to February 2020, he was the global head of healthcare investing at New Enterprise Associates (NEA).
Davids extensive experience building, leading and financing biopharmaceutical companies will add significant value to Novavax board, especially now as we laser-focus on contributing to some of the worlds most daunting healthcare challenges,... More
